← Back
Bio Risk & AI

AIxBio Group Aims for Evaluation Standards in AI Bio Risks

A new working group aims to standardize how AI systems are evaluated for biological misuse potential.
By
Many people attend a formal meeting in a large conference hall, working at desks with laptops.
Foto: Symbolbild | nti.org · Symbolbild (thematisch gesucht: NTI Concordia AI Launch International Working Group to Impro) - nicht das Originalfoto der Quelle.
The essentials
  • The AIxBio Technical Working Group includes participants from China, the EU, the UK, and the US.
  • Biological capability evaluations are used to guide AI risk management decisions.

Experts from China, the European Union, the United Kingdom, and the United States have formed the AIxBio Technical Working Group. This group, organized through the AIxBio Global Forum, aims to standardize how AI systems are evaluated for potential misuse in biological contexts.

Why biological evaluations matter

Biological capability evaluations are growing in importance for managing frontier AI risks. These assessments look at what AI systems can do that might make them easier to misuse. Developers use the results to decide on safeguards, access controls, or changes to deployment strategies. However, the lack of consistency in evaluation methods and reporting can lead to misinterpretation of a system's true capabilities.

For example, a system's performance might change depending on how it is configured or tested. If these differences are not clearly reported, they might be wrongly attributed to the model itself. The Working Group will analyze published evaluation methods to create a shared technical basis and standard terminology for evaluating AI systems.

The group's roadmap

The group's tasks include clarifying what these evaluations actually measure and how they relate to the risks they claim to address. They will explore the conditions under which evaluation results can be reliably compared across different systems and organizations. The group will also distinguish what is established by an evaluation from what it implies about the risk of biological misuse.

Evidentiary standards and the thresholds for taking action based on evaluation results will be closely examined. These documents will help developers, governments, and evaluators interpret and use evaluation evidence more consistently.

Open invitation for collaboration

The group is inviting experts and organizations involved in biological capability evaluations to join. They ask participants to contact Helia Samani at [email protected] to contribute or share their work. This effort complements the AIxBio Forum’s existing group on risk assessment and future threats, aiming to fill a critical gap in AI safety protocols.

The other side

Critics warn that standardizing evaluations might not prevent misuse if AI systems remain too opaque to fully assess.

Frequently asked questions

What is the AIxBio Technical Working Group?

The AIxBio Technical Working Group is a coalition of experts from China, the EU, the UK, and the US aiming to standardize biological capability evaluations of AI systems.

Why are these evaluations important?

They assess AI capabilities that could lower barriers to biological misuse, guiding model developers in safeguarding and risk mitigation decisions.

What will the group publish in 2024?

Methodological findings, voluntary reporting conventions, and research priorities to support consistent interpretation of evaluation evidence.

Based on reporting by The Nuclear Threat Initiative, compiled by the Tradingbird newsroom. Published 07 Aug 2026, 21:39.
Topics: AI · Security

Related

Google reshapes DeepMind leadership for AGI focus · Tech ·

Student accuses school of AI cheating · Tech ·

Apple adds nearly 45 hearing devices to MFi list · Tech ·

Pentagon awards $821M AI data platform contract · Tech ·

IPv6 essential for AI and cloud innovation · Tech ·